Second Sight Medical Products EYESW 深 沪
已收盘 08-30 16:00:00 美东时间
0.2198
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.2198
- 总市值 168.83万
- 52周最高 1.02
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.09
- 委 比 0.00%
- 总股本 768.09万
- 历史最高 13.28
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.025
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Vivani Medical, Inc. reported successful completion of its first-in-human study, LIBERATE-1, and promising preclinical proof of concept data for a semaglutide implant (NPM-139) for chronic weight management. The implant demonstrated sustained exposure and >20% sham-adjusted weight loss for a full year. The company has a strong cash position of $41.5M, supporting operations into mid-2027. Anticipated milestones include Phase 1 results for NPM-139 ...
03-26 20:16
Neuralink联合创始人：脑机接口正进入起飞时代，人类可能活到千岁？
①Neuralink联合创始人Max Hodak在一次采访中指出，脑机接口的本质就是利用大脑的神经接口进行双向通信的技术；②Hodak认为，未来5到10年将出现生物混合神经接口，届时将实现人类意识与机器的深度耦合；③Hodak还大胆预测，首批能活到1000岁的人类可能已诞生。
03-12 15:30
Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026
Cortigent, a leading developer of precision neurostimulation brain implant devices, recently presented successful results from a 6-year Early Feasibility Study of its Orion® Visual Cortical Prosthesis System at the NANS annual meeting. The system, designed for profoundly blind individuals, uses a wirelessly controlled implantable pulse generator and 60 micro-electrodes to deliver visual perception via phosphenes. Study results showed all six subj...
01-29 12:30
Vivani Subsidiary Cortigent to Present Orion System’s Advanced Brain Implant Technology in Poster Session at NANS 2026
<p>Cortigent, a subsidiary of Vivani Medical, Inc., is advancing brain interface technologies to restore vision and mobility. Their Orion system, presented at the NANS meeting, aims to provide meaningful visual perception to the blind through a cortical stimulation platform. Additionally, the company is developing a solution to enhance recovery of arm and hand motion in stroke patients. This innovation builds on their FDA-approved Argus II device...
01-22 12:00
第一批当上“赛博格”的人，已经过了保修期
让瘫痪人士再次行走的外骨骼，让视障者重获光明的可植入视网膜，听起来十分鼓舞人心。健康人也会畅想，如果拥有这样的设备，是不是可以轻松上高原爬雪山，获得夜间视觉，或...
2025-01-10 16:10
Second Sight 医疗产品（纳斯达克股票代码：EYESW）下跌21％
Second Sight Medical Products Inc (NASDAQ:EYESW – Get Rating) shares dropped 21...
2023-01-11 15:41
Second Sight 医疗产品（纳斯达克股票代码：EYESW）交易价格上涨148.8％
Second Sight Medical Products Inc (NASDAQ:EYESW – Get Rating)'s share price was...
2022-12-14 15:02
StockNews.com Initiates Coverage on Second Sight Medical Products (NASDAQ:EYES)
StockNews.com started coverage on shares of Second Sight Medical Products (NASD...
2022-09-21 13:21
Second Sight Medical Products, (NASDAQ:EYESW) Stock Price Up 7.4%
Second Sight Medical Products, (NASDAQ:EYESW – Get Rating)'s share price rose 7...
2022-07-13 14:01
路易斯安那州前总检察长发出的第二视觉医疗投资者警告：Kahn Swick&Foti，LLC调查第二视觉医疗产品公司的合并-Eyes
NEW ORLEANS, Feb. 16, 2022 /PRNewswire/ -- Former Attorney General of Louisiana...
2022-02-17 12:40
